ResearcherVita-Salute San Raffaele UniversityActive in the last 2 years
Maria Giulia Cangi
Matched on ORCID iD 0000-0002-9472-0935; OpenAlex author ID A5052627162. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 5
- Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective Study. Co-author DOI 10.1097/sla.0000000000006920↗
- Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system. Co-author DOI 10.1007/s00428-023-03574-x↗
- Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples. Last author DOI 10.1016/j.cgh.2022.10.014↗
- Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC). Co-author DOI 10.1245/s10434-022-11413-7↗
- Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma. Co-author DOI 10.1007/s00280-015-2932-3↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Claudio Doglioni · 5 shared papers, 2016–2025 · strength 0.72
- Paper Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective Study. DOI 10.1097/sla.0000000000006920↗
- Paper Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system. DOI 10.1007/s00428-023-03574-x↗
- Paper Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC… DOI 10.1245/s10434-022-11413-7↗
- Massimo Falconi · 4 shared papers, 2022–2025 · strength 0.67
- Paper Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective Study. DOI 10.1097/sla.0000000000006920↗
- Paper Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system. DOI 10.1007/s00428-023-03574-x↗
- Paper Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC… DOI 10.1245/s10434-022-11413-7↗
- Marco Schiavo Lena · 4 shared papers, 2022–2025 · strength 0.67
- Paper Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective Study. DOI 10.1097/sla.0000000000006920↗
- Paper Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system. DOI 10.1007/s00428-023-03574-x↗
- Paper Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC… DOI 10.1245/s10434-022-11413-7↗
- Michele Reni · 4 shared papers, 2016–2025 · strength 0.55
- Paper Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective Study. DOI 10.1097/sla.0000000000006920↗
- Paper Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC… DOI 10.1245/s10434-022-11413-7↗
- Paper Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Sampl… DOI 10.1016/j.cgh.2022.10.014↗
- Miriam Redegalli · 3 shared papers, 2022–2023 · strength 0.46
- Paper Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system. DOI 10.1007/s00428-023-03574-x↗
- Paper Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC… DOI 10.1245/s10434-022-11413-7↗
- Paper Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Sampl… DOI 10.1016/j.cgh.2022.10.014↗
- Giulio Belfiori · 2 shared papers, 2023–2025 · strength 0.38
- Giulia Gasparini · 2 shared papers, 2023–2025 · strength 0.38
- Stefano Crippa · 2 shared papers, 2023–2025 · strength 0.38
- Gianpaolo Balzano · 2 shared papers, 2022–2023 · strength 0.29
- Paper Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC… DOI 10.1245/s10434-022-11413-7↗
- Paper Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Sampl… DOI 10.1016/j.cgh.2022.10.014↗
- Paolo Giorgio Arcidiacono · 2 shared papers, 2022–2023 · strength 0.29
- Paper Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC… DOI 10.1245/s10434-022-11413-7↗
- Paper Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Sampl… DOI 10.1016/j.cgh.2022.10.014↗
- Stefano Partelli · 1 shared paper, 2025 · strength 0.21
- Nicolò Pecorelli · 1 shared paper, 2025 · strength 0.21
- Domenico Tamburrino · 1 shared paper, 2025 · strength 0.21
- Claudio Fiorino · 1 shared paper, 2022 · strength 0.15
- Martina Mori · 1 shared paper, 2022 · strength 0.15
- Marina Macchini · 1 shared paper, 2023 · strength 0.14
- Maria Chiara Petrone · 1 shared paper, 2023 · strength 0.14
- Giulia Orsi · 1 shared paper, 2023 · strength 0.14
- Gemma Rossi · 1 shared paper, 2023 · strength 0.14
- Carmen Belli · 1 shared paper, 2016 · strength 0.05
- Luca Porcu · 1 shared paper, 2016 · strength 0.05
- Erica Dugnani · 1 shared paper, 2016 · strength 0.05
- Lorenzo Piemonti · 1 shared paper, 2016 · strength 0.05
- Paola Allavena · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.